Clin2
NCT07642076Possibly a fitRecruiting

L-carnitine supplement for critically ill liver disease patients

Hepatic

Treatments studied

Part of Digestive system clinical trials.

This study tests whether adding L-carnitine (a naturally occurring compound) to standard care helps people with serious liver disease who are in the intensive care unit. L-carnitine may help the body use energy better and reduce complications from liver failure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
58 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have confirmed liver disease and are admitted to an intensive care unit
  • Your liver condition includes one or more of: acute-on-chronic liver failure, hepatic encephalopathy (brain effects from liver disease), spontaneous bacterial peritonitis, bleeding from stomach veins, fulminant hepatitis, hepatorenal syndrome, or ascites (fluid in the belly)
  • You are not pregnant or breastfeeding
  • You do not have a seizure disorder
  • You are not currently taking the blood thinner warfarin

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07201714Recruiting· Early Phase 1
Carnitine supplement for heart failure with kidney issues

This trial tests whether taking carnitine supplements by mouth can help people who have both heart failure and early-to-moderate kidney problems. It's an early-phase study to see if the supplement is safe and works for this group.

London, Ontario
NCT07035444Not yet recruiting
L-carnitine nutrition for weight loss in lung cancer

This trial tests if adding L-carnitine to liquid nutrition can help people with non-small cell lung cancer who are losing weight and muscle mass. It is for those who are on chemotherapy and have lost weight recently.

Chongqing
NCT06753565Recruiting· Phase 2
L-carnitine supplement for rheumatoid arthritis

This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.

Cairo, Demerdash
NCT06564909Recruiting· Phase 2
L-carnitine for heart muscle protection after a heart attack

This trial tests whether the supplement L-carnitine, given during a heart attack procedure, can reduce heart muscle damage. If you are having a STEMI heart attack and are getting angioplasty, you may be able to join.

Cairo
NCT07768228Recruiting· Phase 2
L-carnitine for healing diabetic foot ulcers

This study tests whether a supplement called L-carnitine can help diabetic foot ulcers heal faster. It is for people with type 2 diabetes who have mild to moderate foot ulcers and neuropathy (nerve damage in the feet).

Cairo, Cairo Governorate
NCT07437391Recruiting
L-carnitine for preterm babies with breathing problems

This trial tests whether giving L-carnitine, a nutrient that helps cells make energy, to premature newborns with respiratory distress syndrome (RDS) can improve their health. It may help their bodies cope better in the NICU.

Muzaffargarh, Punjab Province

Hear when a new Hepatic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.